Literature DB >> 20005020

Antimicrobial study of newly synthesized 6-substituted indolo[1,2-c]quinazolines.

Rondla Rohini1, P Muralidhar Reddy, Kanne Shanker, Anren Hu, Vadde Ravinder.   

Abstract

A new series of indolo[1,2-c]quinazoline derivatives were prepared in good yield through reaction of 2-(o-aminophenyl)indole with a variety of arylaldehydes. The structures of the newly synthesized compounds were confirmed by IR, (1)H NMR, (13)C NMR and mass spectral studies and elemental analysis. All the title compounds were investigated for their activity against certain strains of Gram-positive bacteria (Staphylococcus aureus, Bacillus subtilis and Streptococcus pyogenes), Gram-negative bacteria (Salmonella typhimurium, Escherichia coli and Klebsiella pneumonia) and pathogenic Fungi (Aspergillus niger, Candida albicans and Trichoderma viridae). Ampicillin and ketoconazole were used as reference compounds. The results revealed that some of synthesized compounds displayed marked activity against all the tested microorganisms. Copyright (c) 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005020     DOI: 10.1016/j.ejmech.2009.11.038

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  14 in total

1.  Characterizing the Antimicrobial Activity of N2,N4-Disubstituted Quinazoline-2,4-Diamines toward Multidrug-Resistant Acinetobacter baumannii.

Authors:  Renee Fleeman; Kurt S Van Horn; Megan M Barber; Whittney N Burda; David L Flanigan; Roman Manetsch; Lindsey N Shaw
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

2.  Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival.

Authors:  Juan A De La Cruz; Thota Ganesh; Becky A Diebold; Weiping Cao; Amelia Hofstetter; Neetu Singh; Amrita Kumar; James McCoy; Priya Ranjan; Susan M E Smith; Suryaprakash Sambhara; J David Lambeth; Shivaprakash Gangappa
Journal:  PLoS One       Date:  2021-07-19       Impact factor: 3.240

3.  Crystal structure of 3-amino-2-ethyl-quinazolin-4(3H)-one.

Authors:  Gamal A El-Hiti; Keith Smith; Amany S Hegazy; Mohammed Baashen; Benson M Kariuki
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-08-06

4.  Crystal structure of 3-amino-2-propyl-quinazolin-4(3H)-one.

Authors:  Gamal A El-Hiti; Keith Smith; Amany S Hegazy; Saud A Alanazi; Benson M Kariuki
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-07-22

5.  Antibacterial Effects of Quinazolin-4(3H)-One Functionalized-Conjugated Silver Nanoparticles.

Authors:  Abdulkader Masri; Ayaz Anwar; Naveed Ahmed Khan; Muhammad Saquib Shahbaz; Khalid Mohammed Khan; Syed Shahabuddin; Ruqaiyyah Siddiqui
Journal:  Antibiotics (Basel)       Date:  2019-10-09

6.  Synthesis and Evaluation of N-substituted Imidazole Derivatives for Antimicrobial Activity.

Authors:  Namita Gupta; D P Pathak
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975

7.  Quinazoline derivatives: synthesis and bioactivities.

Authors:  Dan Wang; Feng Gao
Journal:  Chem Cent J       Date:  2013-06-03       Impact factor: 4.215

8.  A novel multi-component reaction to imidazo[4,5-g]-quinazolines.

Authors:  Li Li; Qianqian Zhang; Bo Liu; Gang Liu
Journal:  Molecules       Date:  2013-05-16       Impact factor: 4.411

9.  New Isoxazolidine-Conjugates of Quinazolinones-Synthesis, Antiviral and Cytostatic Activity.

Authors:  Dorota G Piotrowska; Graciela Andrei; Dominique Schols; Robert Snoeck; Magdalena Grabkowska-Drużyc
Journal:  Molecules       Date:  2016-07-22       Impact factor: 4.411

10.  Synthesis of indolo[1,2-c]quinazolines from 2-alkynylaniline derivatives through Pd-catalyzed indole formation/cyclization with N,N-dimethylformamide dimethyl acetal.

Authors:  Antonio Arcadi; Sandro Cacchi; Giancarlo Fabrizi; Francesca Ghirga; Antonella Goggiamani; Antonia Iazzetti; Fabio Marinelli
Journal:  Beilstein J Org Chem       Date:  2018-09-14       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.